Patent US4623651A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4623651A Expired / Lapsed US ⏱️ 0.0 years remaining

Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones

Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1985-10-15
•
Granted: 1986-11-18
•
Expires: 2005-10-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Heterocyclocarbonyl- and acetyl-thiazolones enhance myocardial contractile force and are useful as cardiotonics in the treatment of heart failure.

Inventors

  • 👤 J. Martin Grisar
  • 👤 Richard C. Dage
  • 👤 Richard A. Schnettler

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 15:11
CPC Classifications
C; C07; C07D; C07D407/00; C07D407/02; C07D417/00; C07D417/02; C07D417/06; A; A61; A61P; A61P9/00; A61P9/04

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 84 words
A thiazolone of the formula ##STR5## wherein is a hydrogen or (C 1 -C 4 )alkyl group and R 2 is a pyridyl or pyridylmethyl group optionally substituted with a member of the group consisting of a (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )alkylthio, (C 1 -C 4 )alkylsulfinyl, (C 1 -C 4 )alkylsulfonyl, carboxy, carb (C 1 -C 4 )alkoxy, halogen, trifluoromethyl and cyano, or R 2 is a furanyl, furanylmethyl, thienyl or thienylmethyl group.
Claim 2
Dependent Claim 84 words
A thiazolone of the formula ##STR5## wherein is a hydrogen or (C 1 -C 4 )alkyl group and R 2 is a pyridyl or pyridylmethyl group optionally substituted with a member of the group consisting of a (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )alkylthio, (C 1 -C 4 )alkylsulfinyl, (C 1 -C 4 )alkylsulfonyl, carboxy, carb (C 1 -C 4 )alkoxy, halogen, trifluoromethyl and cyano, or R 2 is a furanyl, furanylmethyl, thienyl or thienylmethyl group.
Claim 3
Dependent Claim 15 words
A thiazolone of claim 1 wherein R 1 is a hydrogen, methyl, or ethyl group.
Claim 4
Dependent Claim 15 words
A thiazolone of claim 1 wherein R 2 is a pyridyl or substituted pyridyl group.
Claim 5
Dependent Claim 15 words
A thiazolone of claim 2 wherein R 2 is a pyridyl or substituted pyridyl group.
Claim 6
Dependent Claim 12 words
A thiazolone of claim 1 wherein R 2 is a 4-pyridyl group.
Claim 7
Dependent Claim 12 words
A thiazolone of claim 2 wherein R 2 is a 4-pyridyl group.
Claim 8
Dependent Claim 19 words
A thiazolone of claim 1 wherein R 1 is a methyl group and R 2 is a 4-pyridyl group.
Claim 9
Dependent Claim 28 words
A method of enhancing myocardial contractile force in a patient in need thereof which comprises administering to the patient an effective amount of a thiazolone of claim 1.
Claim 10
Dependent Claim 15 words
A method of claim 8 wherein R 1 is a hydrogen, methyl, or ethyl group.
Claim 11
Dependent Claim 15 words
A method of claim 8 wherein R 2 is a pyridyl or substituted pyridyl group.
Claim 12
Dependent Claim 15 words
A method of claim 9 wherein R 2 is a pyridyl or substituted pyridyl group.
Claim 13
Dependent Claim 12 words
A method of claim 8 wherein R 2 is a 4-pyridyl group.
Claim 14
Dependent Claim 12 words
A method of claim 9 wherein R 2 is a 4-pyridyl group.
Claim 15
Dependent Claim 19 words
A method of claim 8 wherein R 1 is a methyl group and R 2 is a 4-pyridyl group.
Claim 16
Dependent Claim 28 words
A method of treating heart disfunction in a patient in need thereof which comprises administering to the patient a cardiotonically effective amount of a thiazolone of claim 1.
Claim 17
Dependent Claim 15 words
A method of claim 15 wherein R 1 is a hydrogen, methyl, or ethyl group.
Claim 18
Dependent Claim 15 words
A method of claim 15 wherein R 2 is a pyridyl or substituted pyridyl group.
Claim 19
Dependent Claim 15 words
A method of claim 16 wherein R 2 is a pyridyl or substituted pyridyl group.
Claim 20
Dependent Claim 12 words
A method of claim 15 wherein R 2 is a pyridyl group.
Claim 21
Dependent Claim 12 words
A method of claim 16 wherein R 2 is a pyridyl group.
Claim 22
Dependent Claim 20 words
A method of claim 15 wherein R 1 is a methyl group and wherein R 2 is a 4-pyridyl group.

References Cited (Backward Citations)

US4405635A Cited
US4405638A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-11-17 1990-05-19 1990-11-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-11-17 1994-05-19 1994-11-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-11-17 1998-05-19 1998-11-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag